Iterum Therapeutics plc - Ordinary Share (ITRM) earnings
ITRM earnings moved a median of -2.44% by the close. Quarterly and annual ITRM reports and results, each read against the price at its own news timestamp. Back to the ITRM overview →
23 measured ITRM earnings events.
Where these ITRM earnings landedvs 22 measured ITRM earnings reactions
| Middle 50% of ITRM earnings reactions | -4.76% to +3.11% |
|---|---|
| Median reaction (to close) | -2.44% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 ITRM earnings events with a measured close landed between -4.76% and +3.11%; 41% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Iterum Therapeutics plc For: Sep 30 | SEC filing · Form 10-Q | +0.38% | -5.98% | |
| Iterum Therapeutics Reports Third Quarter 2025 Financial Results | Press release | +0.38% | -5.98% | |
| Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 | Press release | +2.72% | +3.60% | |
| Form 10-Q Iterum Therapeutics plc For: Jun 30 | SEC filing · Form 10-Q | +0.79% | -2.58% | |
| Iterum Therapeutics Reports Second Quarter 2025 Financial Results | Press release | +0.79% | -2.58% | |
| Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025 | Press release | -0.61% | — | |
| Form 10-Q Iterum Therapeutics plc For: Mar 31 | SEC filing · Form 10-Q | -0.56% | -4.25% | |
| Iterum Therapeutics Reports First Quarter 2025 Financial Results | Press release | -0.56% | -4.25% | |
| Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 | Press release | +0.00% | -2.29% | |
| Form 10-K Iterum Therapeutics plc For: Dec 31 | SEC filing · Form 10-K | -1.89% | -10.63% | |
| Form 10-Q Iterum Therapeutics plc For: Sep 30 | SEC filing · Form 10-Q | +5.20% | +8.80% | |
| Iterum Therapeutics Reports Third Quarter 2024 Financial Results | Press release | +5.20% | +8.80% | |
| Iterum Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024 | Press release | -0.66% | +0.00% | |
| Form 10-Q Iterum Therapeutics plc For: Jun 30 | SEC filing · Form 10-Q | -0.42% | +1.68% | |
| Iterum Therapeutics Reports Second Quarter 2024 Financial Results | Press release | -0.42% | +1.68% | |
| Iterum Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024 | Press release | +1.36% | -3.64% | |
| Form 10-Q Iterum Therapeutics plc For: Mar 31 | SEC filing · Form 10-Q | -8.77% | -8.43% | |
| Iterum Therapeutics Reports First Quarter 2024 Financial Results | Press release | -8.77% | -8.43% | |
| Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024 | Press release | +0.00% | +3.25% | |
| Form 10-K Iterum Therapeutics plc For: Dec 31 | SEC filing · Form 10-K | +2.13% | -4.94% | |
| Form 10-Q Iterum Therapeutics plc For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +8.22% | |
| Iterum Therapeutics Reports Third Quarter 2023 Financial Results | Press release | +0.00% | +8.22% | |
| Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023 | Press release | — | +2.70% |
Keep exploring
More ITRM: analyst actions → · SEC filings → · ITRM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BODY AND MIND INC (BMMJ) | 168 | 0.00% | 31% |
| Bio-Path Holdings, Inc. (BPTH) | 168 | 0.00% | 43% |
| BIOSTAR PHARMS INC (BSPM) | 167 | 0.00% | 41% |
| Sonoma Pharmaceuticals, Inc. (SNOA) | 167 | -0.32% | 42% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.